Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
GI

Genesis Ibrc India Ltd

514336·Pharmaceuticals

Genesis IBRC India Ltd (Formerly SSK Lifestyles Limited) is in the business of Biotechnology.Product Profile: a) Aquaculture Probiotic: Proteomix Protein Balanced Gel, Yuccagen Ammonia Controller, Growfast Gen Single Cell Protein, Progutgen Aquaculture Gut Probiotic, Rhodogen PS -Water Probiotic b) Aqua Feed Supplement: Moultigen Aqua EDTA Aqua Culture, Vitagen C Aqua...

63Announcements
17-04-2026Last filed
0Last 90 days
genesisbrc.com

What Genesis files

  • Important23
  • Insider Trading13
  • Others12
  • Board Meeting9
  • Updates3
  • Results2
Showing Updates announcements (3)Clear filter
04-07-2025 · 06:05 pm

Genesis IBRC India Limited has announced compliance confirmation for the quarter ended June 30, 2025, from its Registrar and Transfer Agent, Venture Capital and Corporate Investments Private Limited. The certificate confirms that securities received for dematerialisation were verified, mutilated, and cancelled, with the depositories' records updated within 15 days of...

Read the full announcement→
PDF
30-06-2025 · 07:25 pm

Genesis IBRC India Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company reported total income of ₹366.72 lakhs for the year ended, with employee expenses at ₹5.10 lakhs and other expenses totaling ₹11.14 lakhs. It recorded a net profit of ₹350.48...

Read the full announcement→
PDF
29-05-2025 · 10:01 pm

Genesis IBRC India Limited has clarified that Regulation 32(1) related to disclosure of deviations in fundraising proceeds is not applicable, as the company has not raised any funds through public issue, rights issue, preferential allotment, or QIP. Therefore, no statement on variation or deviation in utilization of issue proceeds is...

Read the full announcement→
PDF